Pylarify eu locamedz approval date?

When was Pylarify (piflufolastat F 18) approved in the EU?

Pylarify (piflufolastat F 18) received its European Union approval on 7 November 2023 [1].

What is Pylarify (and what is it used for in the EU)?

Pylarify is a radiopharmaceutical used for positron emission tomography (PET) imaging. In the EU, it is indicated for detection of prostate-specific membrane antigen (PSMA)-positive lesions in patients with prostate cancer when appropriate for clinical management (based on the EU label) [1].

Where can I verify the approval date?

The EU approval date is published by the European Medicines Agency (EMA) and is linked to the marketing authorisation for Pylarify [1].

Sources:
[1] https://www.ema.europa.eu/en/medicines/human/EPAR/pylarify